VIR
Vir Biotechnology, Inc. · Healthcare
President and CEO George A Scangos sold $681K of Vir Biotechnology, Inc.
Sold$680,747
$24.53Price
27,750Shares
What VIR did after the filing
- The stock from Fri, Feb 24 close, $23.00
- +3.3%
- S&P 500, same days
- +3.7%
Measured over 30 trading days, to the Apr 10 close.
Traded Thu, Feb 23. Filed Fri, Feb 24, 3:34 PM ET, during the session. Returns use the Feb 24 close and the Apr 10 close. Not investment advice.